Global Health Limited (ASX: GLH) (GLH or the Company), in accordance with ASX Listing Rule 3.16.1, is pleased to announce the appointment of Ms Anara Malabekova as Joint Company Secretary of the Company and its Australian subsidiaries, effective immediately. Ms Malabekova is the Company’s Financial Controller,...
View the market update presentation here: Oct-24 Investor Market Update....
Result highlights include: Annual Recurring Revenue up 13% on PCP Cash receipts up 13% on the Previous Corresponding Period (PCP) Net Operating and Investing cashflow reduced by 14% from PCP Group Cashflow deficit reduced by 28% from PCP Global Health Limited (ASX: GLH) (“Global Health” or...
We are pleased to announce that Global Health Limited (ASX: GLH) has transferred its share registry services from Link Market Services to Boardroom Pty Limited, effective Monday, 7 October 2024. This transition will provide shareholders with enhanced access to their shareholding information and services through Boardroom's...
Global Health achieves turnaround results in 2024 Global Health Limited (ASX:GLH) (“Global Health” or “the Group”) is pleased to release its 2024 Annual Report, announcing a transformational 12 months to June 2024 completing a turnaround which positions the group to transition back into sustainable profitability and...
Result highlights include: Operating Cashflow Growth: Operating cashflow in the June-24 quarter surged by 666% compared to June-23, reaching $419K. Strong Financial Position: Closing cash balance as of 30 June 2024 stood at $2.066M, inclusive of $596K in Convertible Notes. Successful Implementation of MasterCare: MasterCare...
Placement of Convertible Notes, raising up to $1,000,000 before costs; Funds raised to provide a buffer to available cash in the event the challenging business conditions impacting on hospital clients worsen; The Company’s directors have each subscribed for $50,000 (subject to shareholder approval). Global Health...
Result highlights include: Year To Date (YTD) Revenue to March up 12% on the Previous Corresponding Period (PCP) Operating Cashflow improves by 69% from the PCP Group Cashflow improves by 61% from the PCP Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased...
Result highlights include: Revenue up 27% or $856K to $4.039M Expenses reduced by 12% or $0.69M to ($5.2M) EBITDA up 58% or $1.5M to ($1M) Innovation investments (R&D) increase 84% to $1.468M Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release...
Global Health is excited to present our Annual Report, showcasing our achievements in the past year. The highlights include: 20% increase in Customer Revenue to $7.81 million 11% growth in Annual Recurring Revenue reaching $5.73 million 47% rise in Gross Margin, totaling $4.12 million. In addition, we...